JP2013506672A5 - - Google Patents

Download PDF

Info

Publication number
JP2013506672A5
JP2013506672A5 JP2012532138A JP2012532138A JP2013506672A5 JP 2013506672 A5 JP2013506672 A5 JP 2013506672A5 JP 2012532138 A JP2012532138 A JP 2012532138A JP 2012532138 A JP2012532138 A JP 2012532138A JP 2013506672 A5 JP2013506672 A5 JP 2013506672A5
Authority
JP
Japan
Prior art keywords
prv
immunogenic composition
polypeptide
seq
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012532138A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013506672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/051346 external-priority patent/WO2011041789A1/en
Publication of JP2013506672A publication Critical patent/JP2013506672A/ja
Publication of JP2013506672A5 publication Critical patent/JP2013506672A5/ja
Pending legal-status Critical Current

Links

JP2012532138A 2009-10-02 2010-10-04 魚類レオウイルス免疫原性組成物 Pending JP2013506672A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24805809P 2009-10-02 2009-10-02
US61/248,058 2009-10-02
US32504710P 2010-04-16 2010-04-16
US61/325,047 2010-04-16
US38059410P 2010-09-07 2010-09-07
US61/380,594 2010-09-07
PCT/US2010/051346 WO2011041789A1 (en) 2009-10-02 2010-10-04 Piscine reovirus immunogenic compositions

Publications (2)

Publication Number Publication Date
JP2013506672A JP2013506672A (ja) 2013-02-28
JP2013506672A5 true JP2013506672A5 (enExample) 2013-11-21

Family

ID=43826692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532138A Pending JP2013506672A (ja) 2009-10-02 2010-10-04 魚類レオウイルス免疫原性組成物

Country Status (8)

Country Link
US (3) US9366667B2 (enExample)
EP (2) EP2482825B1 (enExample)
JP (1) JP2013506672A (enExample)
CN (1) CN102647988A (enExample)
CA (2) CA2776386C (enExample)
CL (5) CL2012000822A1 (enExample)
DK (1) DK179132B1 (enExample)
WO (2) WO2011041789A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
CA2922621C (en) * 2013-08-30 2023-05-23 Pharmaq As Method for propagating piscine orthoreovirus
IL230970A0 (en) 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CL2015000980A1 (es) * 2014-04-18 2016-07-01 Upstartdna Co Ltd Standard Entity Métodos para detectar patógenos en peces de agua fría.
WO2015185605A1 (en) * 2014-06-03 2015-12-10 Veterinærinstituttet New reovirus infecting rainbow trout
WO2016075277A1 (en) 2014-11-14 2016-05-19 Patogen Analyse As Novel fish virus and method for detection
CN114057841A (zh) 2014-12-15 2022-02-18 纽约市哥伦比亚大学理事会 新型罗非鱼病毒及其用途
CA3083873A1 (en) 2017-12-06 2019-06-13 Intervet International B.V. Use of a non-structural protein from prv to protect against heart and skeletal muscle inflammation
WO2020069656A1 (zh) * 2018-10-05 2020-04-09 福又达生物科技股份有限公司 鱼病原体检测方法
US10688050B1 (en) 2018-12-21 2020-06-23 Synthon B.V. Pharmaceutical composition comprising ibrutinib
NO344967B1 (en) 2019-01-30 2020-08-03 Patogen As Piscine Orthoreovirus Virulence Markers
CN109971890A (zh) * 2019-04-30 2019-07-05 上海海洋大学 Ii型草鱼呼肠孤病毒的微滴式数字pcr检测试剂盒及其专用引物和探针
CN110079507B (zh) * 2019-05-06 2022-05-20 中国海洋大学 抗牙鲆黏膜免疫球蛋白IgT的单克隆抗体及其应用
CN110408637B (zh) * 2019-08-08 2020-12-25 中国水产科学研究院长江水产研究所 一种草鱼出血病酵母口服疫苗及应用
CA3158539A1 (en) 2019-12-16 2021-06-24 Johanna Jacoba Elisabeth Bijlsma Inactivated piscine orthoreovirus vaccine
NO346211B1 (en) 2020-07-14 2022-04-19 Patogen As Piscine Orthoreovirus Virulence Markers
CN112206317B (zh) * 2020-10-12 2023-09-22 浙江省淡水水产研究所 一种草鱼出血病二价核酸菌蜕疫苗的制备方法
CN112048575A (zh) * 2020-10-26 2020-12-08 深圳市莱孚生物科技有限公司 一种用于鉴定草鱼出血热病毒的引物及探针以及检测方法
CN113527475B (zh) * 2021-06-07 2022-04-29 浙江省农业科学院 一种分泌鸭新型呼肠孤病毒σC蛋白单抗的杂交瘤细胞、单抗及应用
CN114164159B (zh) * 2021-06-21 2023-10-03 湖南师范大学 一种具有防治鱼类杀鲑气和迟缓爱德华氏菌感染的二联疫苗及其制备方法与应用
KR102734012B1 (ko) * 2021-08-19 2024-11-25 성균관대학교산학협력단 바이러스성 출혈성 패혈증 바이러스에 특이적으로 결합하는 항체 또는 이의 항원 결합 단편, 및 이들의 용도
CL2024000227A1 (es) * 2024-01-25 2024-07-12 Univ Santiago Chile Proteína de piscine orthoreovirus; composición de vacuna; y su uso.
CN118853676B (zh) * 2024-09-03 2025-03-07 中国水产科学研究院淡水渔业研究中心 一种草鱼ii型呼肠孤病毒反义rna及其重组载体、试剂盒和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
WO1986006487A1 (en) 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
NZ215865A (en) 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
EP1380651A2 (en) 1991-08-26 2004-01-14 Baxter Healthcare S.A. Recombinant fowlpox virus with intact FPV-tk-gene
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
US6719980B1 (en) 1998-05-08 2004-04-13 Akzo Nobel Nv Structural proteins of fish pancreatic disease virus and uses thereof
US20080256662A1 (en) * 1999-05-10 2008-10-16 Byrum Joseph R Nucleic acid molecules and other molecules associated with plants
DE60024100D1 (de) 1999-08-03 2005-12-22 Akzo Nobel Nv Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
CA2378437C (en) 1999-08-07 2014-01-21 Novartis Ag Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
ATE286507T1 (de) 1999-10-18 2005-01-15 Akzo Nobel Nv Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen
AU2001240791A1 (en) 2000-03-11 2001-09-24 Novartis Ag Sequence
CA2325088A1 (en) * 2000-12-01 2002-06-01 Fusogenix Inc. Novel membrane fusion proteins derived from poikilothermic reovirus
US6979733B2 (en) * 2001-08-03 2005-12-27 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
US7670604B2 (en) 2002-12-13 2010-03-02 Aurelium Biopharma, Inc. Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
WO2004065415A2 (en) 2003-01-20 2004-08-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. L-amino acid oxidase with cytotoxic activity from aplysia punctata
GB2429711B (en) 2004-06-11 2008-05-21 Pharmaq As Heart and skeletal muscle inflammation (HSMI) virus
US7361468B2 (en) * 2004-07-02 2008-04-22 Affymetrix, Inc. Methods for genotyping polymorphisms in humans
CN101128768A (zh) 2005-02-22 2008-02-20 日本碍子株式会社 光调制器
US8088976B2 (en) 2005-02-24 2012-01-03 Monsanto Technology Llc Methods for genetic control of plant pest infestation and compositions thereof
WO2007020983A1 (ja) * 2005-08-18 2007-02-22 Japan Science And Technology Agency オオムギｅｓｔ配列を利用して作製された二倍体コムギ遺伝地図を用いるコムギの育種方法
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
MX2009009530A (es) 2007-03-07 2010-05-19 Nventa Biopharmaceuticals Corp Composiciones de acidos nucleicos cerrados bicatenarios.
CA2678721C (en) 2007-03-12 2018-02-13 Oncolytics Biotech Inc. Reoviruses having modified sequences
WO2010024284A1 (ja) * 2008-09-01 2010-03-04 国立大学法人 北海道大学 魚類抗ウイルスワクチン、魚類免疫賦活剤、および魚類免疫付与方法
WO2011041789A1 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions

Similar Documents

Publication Publication Date Title
JP2013506672A5 (enExample)
Qi et al. The humoral response and antibodies against SARS-CoV-2 infection
Martinez-Flores et al. SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants
Yong et al. Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus
DK201170227A (en) Piscine reovirus immunogenic compositions
Mahgoub An overview of infectious bursal disease
Soy et al. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review
JP2017530124A5 (enExample)
O’Ryan Rotavirus Vaccines: a story of success with challenges ahead
Chen et al. Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with alum induces protective immunity and reduces immune enhancement
Li et al. Development of a recombinant VP2 vaccine for the prevention of novel variant strains of infectious bursal disease virus
Tan et al. Vaccine against norovirus
KR101554080B1 (ko) 1b형 소 바이러스성 설사 바이러스 백신 조성물 및 방법
Song et al. Plant‐based, adjuvant‐free, potent multivalent vaccines for avian influenza virus via Lactococcus surface display
CN102465144A (zh) 柯萨奇病毒a16型病毒样颗粒疫苗
EP2419124A2 (en) Foot-and mouth disease marker vaccine
Fan et al. Genotype I of Japanese encephalitis virus virus-like particles elicit sterilizing immunity against genotype I and III viral challenge in swine
Rey et al. Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice
Soria et al. Immune response and partial protection against heterologous foot‐and‐mouth disease virus induced by dendrimer peptides in cattle
Lee et al. Newly emerging human coronaviruses: animal models and vaccine research for SARS, MERS, and COVID-19
Bedekar et al. Types of vaccines used in aquaculture
Kochinger et al. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection
US20240408189A1 (en) Multi-cbv vaccine for preventing or treating type i diabetes
JP2020537526A5 (enExample)
Lim et al. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials